Jerome B Zeldis Nex Immune, Inc. (NEXI) insider trading activity

NEXI Quotes by TradingView

Jerome B Zeldis is Executive VP of Research & Dev of NexImmune, Inc.. Currently has a direct ownership of 5,882 shares of NEXI, which is worth approximately $1,588. The most recent transaction as insider was on Feb 17, 2021, when has been sold 5,882 shares (Common Stock) at a price of $17.0 per share, resulting in proceeds of $99,994. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.88K
0% 3M change
0% 12M change
Total Value Held $1,588

JEROME B ZELDIS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 17 2021
BUY
Open market or private purchase
$99,994 $17.0 p/Share
5,882 Added 50.0%
5,882 Common Stock

Also insider at

PTCT
PTC THERAPEUTICS, INC. Healthcare
NXGL
NEXGEL, INC. Healthcare
Director
SNGX
SOLIGENIX, INC. Healthcare
JBZ

Jerome B Zeldis

Executive VP of Research & Dev
South Plainfield, NJ

Track Institutional and Insider Activities on NEXI

Follow NexImmune, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NEXI shares.

Notify only if

Insider Trading

Get notified when an Nex Immune, Inc. insider buys or sells NEXI shares.

Notify only if

News

Receive news related to NexImmune, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NEXI